Other roles of Ki67 in breast cancer management have also emerged in recent years, such as triaging care during the Covid-19 pandemic, where Ki67 has been proposed as an objective method of identifying women who should have a high priority for surgery or neoadjuvant chemotherapy when access to these treatments is limited (20,21). Here, MKI67 is linked to breast carcinoma.